Want to join the conversation?
Diagnostics, $HOLX's largest business, grew 2Q16 sales 3.2% in constant currency. Cytology and Perinatal sales grew 3.5%. Molecular Diagnostics sales grew 5.8%, with higher domestic sales due to fully automated Panther system accumulating new placements and wins. Blood screening sales fell 2.4% and Skeletal Health sales fell 8.2% in 2Q16.
$NFLX a monster move, going up. Expect making some money on Monday.
$AMD down more than 6% even after posting above consensus third quarter results.
$MCD stock rose more than 2% after it posted better than expected 3Q16 results, driven by global same-store sales growth. Meanwhile, earnings and revenue were lower than last year, hurt by refranchising efforts.